Sulfonamides Market , By Product Type (Sulfadiazine, Sulfamethoxazole, Sulfasalazine, Sulfisoxazole, Sulfathiazole, Sulfapyridine, Sulfacetamide, and Others (fixed-dose sulfonamide combinations)),By Route of Administration (Oral, Parenteral, and Topical), By Application(Urinary tract infections, Respiratory tract infections, Gastrointestinal infections, Ophthalmic infections, Skin and soft-tissue infections, HIV-associated opportunistic infections, and Veterinary infections),By Class (Short-acting sulfonamides, Intermediate-acting sulfonamides, Long-acting sulfonamides, and Combination sulfonamides (TMP-SMX) ), By Formulation (Tablets, Capsules, Suspensions, Injectables, Ointments and creams, and Ophthalmic solutions), By Prescription Type (Prescription-Based and Over-the-Counter (OTC)), By Status (Branded/Patented Drugs and Generic Drugs), By End User (Hospitals, Clinics, and Veterinary hospitals and clinics), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), By Geography ( North America, Latin America, Europe, Asia Pacific, Middle East, Africa) - Growth Trends and Forecasts (2025-2032)